Florida and Georgia, two states where politicians oppose U.S. President Barack Obama's healthcare law, said on Tuesday that insurance rates for individuals would rise sharply in 2014 under the reform.
Florida and Georgia, two states where politicians oppose U.S. President Barack Obama's healthcare law, said on Tuesday that insurance rates for individuals would rise sharply in 2014 under the reform.
The remarks are part of an increasingly polarized debate over whether "Obamacare" will prove affordable for millions of uninsured Americans when new health plans become available on state-based exchanges as of Oct. 1.
Several states that have embraced the healthcare reform have shown residents how the law will reduce insurance costs, while those that have opposed its implementation are beginning to present it as a more expensive prospect for consumers.
Read the full story here: http://reut.rs/15viKdf
Source: Reuters
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
New TROPiCS-02 Data Back Sacituzumab Govitecan for Older Patients With Breast Cancer
December 9th 2023This phase 3 study investigated sacituzumab govitecan, a Trop-2–directed antibody-drug conjugate, vs treatment of physician’s choice in pretreated patients who have endocrine-resistant hormone receptor–positive/HER2-negative breast cancer, the most common form of breast cancer.
Read More
Insufficient Data, Disparities Plague Lung Cancer Risk Factor Documentation
September 24th 2023On this episode of Managed Care Cast, we speak with the senior author of a study published in the September 2023 issue of The American Journal of Managed Care® on the importance of adequate and effective lung cancer risk factor documentation to determine a patient's eligibility for screening.
Listen
Patients With RA in Remission Withdrawing From TNF Inhibition Show Flare Increases
December 8th 2023New data presented at ACR 2023 highlighted the differences in rates of flares and Boolean 2.0 remission rates compared to patients with rheumatoid arthritis who continued a tumor necrosis factor inhibitor (TNFi).
Read More